Rapamycin-induced apoptosis is p53-independent in human prostate carcinoma PC-3 cells

C Ahn1, M Hwang, P Ramsamooj

  • 1GEORGETOWN UNIV,DEPT RADIAT MED,WASHINGTON,DC 20007. US FDA,DIV ONCOL,ROCKVILLE,MD 20857. US FDA,DIV DRUG PROD & RES & TESTING,ROCKVILLE,MD 20857.

Insights

Rapamycin triggers prostate cancer cell death and growth arrest by increasing p21(waf1) levels, independent of p53. This suggests p21(waf1) induction is key to rapamycin

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Cell Biology

Background:

  • Prostate cancer remains a significant health concern.
  • Understanding drug mechanisms is crucial for effective treatment.

Purpose of the Study:

  • To investigate the molecular mechanisms of rapamycin's effects on PC-3 prostate cancer cells.
  • To elucidate the role of p21(waf1) in rapamycin-induced apoptosis and growth inhibition.

Main Methods:

  • Cell culture of PC-3 prostate carcinoma cells.
  • Treatment with rapamycin.
  • Analysis of gene and protein expression (p21(waf1), pRb, p70 S6 kinase).
  • Cell cycle analysis.

Main Results:

  • Rapamycin induced apoptosis and p21(waf1) expression independently of p53.
  • Rapamycin decreased cdk2 activity and increased hypophosphorylated pRb.
  • Rapamycin treatment led to p70 S6 kinase dephosphorylation and G(1) cell cycle arrest.

Conclusions:

  • Rapamycin-induced growth arrest and apoptosis in PC-3 cells are mediated by the p53-independent induction of p21(waf1).
  • Early induction of p21(waf1) and G(1) arrest are likely critical components of rapamycin's apoptotic mechanism in this cell line.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...